NO951966L - - Google Patents

Info

Publication number
NO951966L
NO951966L NO951966A NO951966A NO951966L NO 951966 L NO951966 L NO 951966L NO 951966 A NO951966 A NO 951966A NO 951966 A NO951966 A NO 951966A NO 951966 L NO951966 L NO 951966L
Authority
NO
Norway
Prior art keywords
mofene
mycophenolate
angioplasty
stenosis
administering
Prior art date
Application number
NO951966A
Other languages
English (en)
Norwegian (no)
Other versions
NO951966D0 (enrdf_load_html_response
Inventor
Elisabeth B Fraser-Smith
Anthony C Allison
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1992/009932 external-priority patent/WO1994012184A1/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO951966D0 publication Critical patent/NO951966D0/no
Publication of NO951966L publication Critical patent/NO951966L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO951966A 1992-11-24 1995-05-18 NO951966L (enrdf_load_html_response)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98083892A 1992-11-24 1992-11-24
CA002144189A CA2144189A1 (en) 1992-11-24 1992-11-24 Prevention of stenosis
PCT/US1992/009932 WO1994012184A1 (en) 1992-11-24 1992-11-24 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis

Publications (2)

Publication Number Publication Date
NO951966D0 NO951966D0 (enrdf_load_html_response) 1995-05-18
NO951966L true NO951966L (enrdf_load_html_response) 1995-05-18

Family

ID=27169974

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951966A NO951966L (enrdf_load_html_response) 1992-11-24 1995-05-18

Country Status (2)

Country Link
CA (1) CA2144189A1 (enrdf_load_html_response)
NO (1) NO951966L (enrdf_load_html_response)

Also Published As

Publication number Publication date
CA2144189A1 (en) 1994-06-09
NO951966D0 (enrdf_load_html_response) 1995-05-18

Similar Documents

Publication Publication Date Title
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
NO179582C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive hydroksamsyre- og N-hydroksyurinstoff-derivater
MX9603479A (es) Derivados de 4-amino de acido micofenolico con actividad inmunosupresora.
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
DK275488A (da) Indolonderivater
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
NO155244C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-substituert-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer fra deres tilsvarende nitriler.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO951966L (enrdf_load_html_response)
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
NO974267L (no) Aminotetralinderivat for behandling av kardiovaskulære sykdommer
MX9603477A (es) Acido micofenolico 4-amino 6-sustituido y derivados con actividad inmunosupresora.
DK360388A (da) Laegemiddel til behandling af hjerteinsufficiens
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
NO177495C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glyserinderivater
NO177705C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive ascorbinsyrederivater
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
PT769962E (pt) Metodo de atenuacao da estenose arterial
ATE168690T1 (de) Indolderivate, ihre salze und sie enthaltende arzneimittel zur behandlung von herzkrankheiten
FI883730A0 (fi) Etrar och tioetrar med terapeutisk effekt, framstaellning av dessa och farmaceutiska sammansaettningar som innehaoller dem.
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen